¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"enzymatic fat necrosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pararenal fat pad
    ÄáÆÏÁÖÀ§Áö¹æµ¢ÀÌ, ÄáÆÏÁÖÀ§Áö¹æÃ¼
  • perirenal fat
    ÄáÆÏÁÖÀ§Áö¹æ
  • subcutaneous fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
  • angiosclerotic necrosis
    Ç÷°ü°æÈ­±«»ç
  • anterior segment necrosis
    ¾È±¸¾ÕºÎºÐ±«»ç
  • arteriolar necrosis
    ¼¼µ¿¸Æ±«»ç
  • aseptic necrosis
    ¹«±Õ±«»ç
  • avascular necrosis
    ¹«Ç÷°ü±«»ç, ¹«Ç÷¼º±«»ç
  • acute tubular necrosis
    ±Þ¼º¿ä¼¼°ü±«»ç
  • bacillary necrosis
    ¸·´ë±Õ±«»ç
  • coagulation necrosis
    ÀÀ°í±«»ç
  • colliquative necrosis
    ¾×È­±«»ç
  • cortical necrosis
    °ÑÁú±«»ç, ÇÇÁú±«»ç
  • cystic medial necrosis
    ³¶¼ºÁß°£¸·±«»ç
  • caseous necrosis
    Ä¡Á»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • infrapatellar fat pad
    ¹«¸­¹ØÁö¹æÃ¼
  • mutton-fat keratic precipitate
    ±»±â¸§°¢¸·Ä§Âø¹°
  • pararenal fat pad
    ÄáÆÏÁÖÀ§Áö¹æÃ¼
  • angiosclerotic necrosis
    Ç÷°ü°æÈ­±«»ç
  • anterior segment necrosis
    ¾È±¸¾ÕºÎºÐ±«»ç
  • arteriolar necrosis
    ¼¼µ¿¸Æ±«»ç
  • aseptic necrosis
    ¹«±Õ±«»ç
  • avascular necrosis
    ¹«Ç÷°ü±«»ç
  • bacillary necrosis
    °£±Õ¼º±«»ç
  • caseous necrosis
    Ä¡Á»ç, °Ç¶ô±«»ç
  • central hemorrhagic necrosis
    Áß½ÉÃâÇ÷±«»ç
  • centrilobular necrosis
    Á߽ɼҿ±±«»ç
  • coagulation necrosis
    ÀÀ°í±«»ç
  • colliquative necrosis
    ¾×È­±«»ç
  • cortical necrosis
    °ÑÁú±«»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • renal papillary necrosis
    ½ÅÀ¯µÎ±«»ç(ãìêáÔéÎÕÞÝ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fat droplet
    Áö¹æ¹æ¿ï
  • fat embolism
    Áö¹æÀü»ö
  • fat embolism
    Áö¹æ»öÀüÁõ(ò·Û¸ßáîûñø)
  • fat embolism,coagulopathy theory
    ÀÀ°íÀå¾ÖÀÌ·Ð
  • fat embolism,emulsion instability stress theory
    À¯¾×ºÒ¾ÈÁ¤ Àڱؼ³
  • fat graft
    Áö¹æÀÌ½ÄÆí(¡­ÀÌ½ÄÆí).
  • fat graft
    Áö¹æÀ̽Ä
  • fat graft
    Áö¹æÀÌ½ÄÆí(¡­ì¹ãÕø¸).
  • fat hypertrophy
    Áö¹æ ºñÈÄ
  • fat image
    Áö¹æ ¿µ»ó
  • fat indigestion
    Áö¹æ¼ÒÈ­ºÒ·®.
  • fat induced hyperlipemia
    ÁöÁúÀ¯µµ¼º °íÁö¹æÇ÷Áõ.
  • fat lime
    ºÎ¼®È¸(Ý£à´üé).
  • fat lobule
    Áö¹æ ¼Ò¿±
  • fat meal
    Áö¹æ½Ä(ò·Û¸ãÝ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FF degree of fineness of abrasive particles; fat-free; father factor; fecal frequency; fertility factor...
FFDW fat-free dry weight
FFE fast field echo; fecal fat excretion
FFG free fat graft
FFM fat-free mass; fundus flavimaculatus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FM% Fat Mass
FFW Fat free weight
FSC Fat storing cells
FFBM Fat-free body mass
FFM Fat-free body mass
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • contraction band necrosis
    ¼öÃà´ë ±«»ç
  • diffuse cortical necrosis
    ¹Ì¸¸¼º ÇÇÁú ±«»ç
  • electrical necrosis
    Àü±â¼º ±«»ç
  • embolic necrosis
    »öÀü¼º ±«»ç
  • liquefaction necrosis
    ¾×È­ ±«»ç
    °­ÇÑ °¡¼öºÐÇØ È¿¼ÒÀÇ ÀÛ¿ëÀ¸·Î ¹ß»ýÇÏ´Â ±«»ç.
  • local necrosis
    ±¹¼Ò ±«»ç
    ±«»ç¶õ ¼¼Æ÷ÀÇ Á×À½À» ³ªÅ¸³»´Â ÇüÅÂÇÐÀû º¯È­ÀÇ ÃÑÈ­·Î¼­ È¿¼ÒÀÇ ÁøÇ༺ ÅðÇ༺ ÀÛ¿ë¿¡ ÀÇÇØ¼­ ÀϾ´Ù. ¼¼Æ÷ ±º, ¶Ç´Â ±¸Á¶¹°À̳ª ±â°üÀÇ ºÎºÐÀ» ħ½ÀÇÑ´Ù. ÀÌ·¯ÇÑ ±«»ç°¡ ÀÏÁ¤ÇÑ Á¼Àº ¿µ¿ª¿¡¼­¸¸ ÀϾ´Â ±¹¼ÒÀû ±«»ç¸¦ ¸»ÇÑ´Ù.
  • medial necrosis
    ÁßÃþ ±«»ç, µ¿¸Æ±ÙÃþ ±«»ç
  • mummification necrosis
    ¹ÌÀ̶óÈ­ ±«»ç
  • myocardial necrosis
    ½É±Ù ±«»ç
  • necrosis
    񮯇
    Á¶Á÷ÀÇ Á×À½. È¿¼ÒÀÇ Á¡ÁøÀûÀÎ ÅðÇ༺ ÀÛ¿ë¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ¼¼Æ÷ Á×À½À» ¾Ï½ÃÇÏ´Â ÇüÅÂÇÐÀû º¯È­ÀÇ ÃÑ ÇÕ. ±×°ÍÀº ¼¼Æ÷ ÁýÇÕ, ±¸Á¶ÀÇ ÀϺκРȤÀº ±â°ü¿¡ ÇØ¸¦ ³¢Ä¡°Ô µÈ´Ù.
  • pressure molding machine

    pressure necrosis

    ¾Ð¹Ú ±«»ç
  • pulp necrosis
    Ä¡¼ö ±«»ç
  • pulpal necrosis
    Ä¡¼ö ±«»ç
  • punched out necrosis
    õ°øµÈ ±«»ç
  • radiation necrosis
    ¹æ»ç¼± ±«»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
necrosis <pathology> The sum of the morphological changes indicative of cell death and caused by the progressive degradative action of enzymes, it may affect groups of cells or part of a structure or an organ.
Origin: Gr. Nekrosis = deadness
(18 Nov 1997)
necrosis bacillus A species of gram-negative, non-spore-forming bacteria isolated from the natural cavities of man and other animals and from necrotic lesions, abscesses, and blood.
(12 Dec 1998)
suppurative necrosis Liquefactive necrosis with pus formation.
(05 Mar 2000)
dental pulp necrosis Death of pulp tissue. When the necrosis is due to ischemia with superimposed bacterial infection, it is referred to as pulp gangrene.
(12 Dec 1998)
infectious pancreatic necrosis virus The type species of aquabirnavirus, causing infectious pancreatic necrosis in salmonid fish and other freshwater and marine animals including mollusks.
(12 Dec 1998)
ischemic necrosis Necrosis caused by hypoxia resulting from local deprivation of blood supply, as by infarction.
(05 Mar 2000)
total necrosis Complete necrosis of the cytologic and histologic elements in a portion of tissue, as in caseous necrosis, death of an entire organ or part.
(05 Mar 2000)
epiphysial aseptic necrosis Aseptic necrosis of bony epiphyses, probably due to ischemia; it may affect the upper end of the femur (Legg-Calve-Perthes disease), the tibial tubercle (Osgood-Schlatter disease), the tarsal navicular bone or the patella (Kohler's disease), the second metatarsal head (Freiberg's disease), vertebral bodies (Scheuermann's disease), or the capitellum of the humerus (Panner's disease).
(05 Mar 2000)
tumor necrosis factor <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin.
Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine.
Synonym: cachectin.
Acronym: TNF
(13 Nov 1997)
tumour necrosis factor <cytokine> Originally described as a tumour inhibiting factor in the blood of animals exposed to bacterial lipopolysaccharide or Bacille Calmette-Guerin.
Preferentially kills tumour cells in vivo and in vitro, causes necrosis of certain transplanted tumours in mice and inhibits experimental metastases. Human Tumour Necrosis factor alpha is a protein of 157 amino acids and has a wide range of pro inflammatory actions. Usually considered a cytokine.
Synonym: cachectin.
Acronym: TNF
(13 Nov 1997)
tumour necrosis factor-beta <cytokine> A cytolytic factor that is produced by CD4 and CD8 T-cells after their exposure to an antigen.
(05 Mar 2000)
kidney cortex necrosis The death of all the functioning renal cells of the kidney cortex with continued viability of the majority of the medullary units. It is due usually to the arterial distribution peculiar to the kidney which makes the renal cortex more susceptible to diminished blood flow.
(12 Dec 1998)
kidney papillary necrosis A form of acute kidney disease characterised by necrosis of the renal papillae. It is most frequently associated with diabetes mellitus because of the severe vascular disease present in the arteries and capillaries, particularly in the kidney. There is usually a large component of infection present, and in non-diabetics pyelonephritis and obstructive uropathy are the usual aetiologic agents.
(12 Dec 1998)
kidney tubular necrosis, acute Acute kidney failure resulting from destruction of tubular epithelial cells. It is commonly attributed to exposure to toxic agents or renal ischemia following severe trauma.
(12 Dec 1998)
Zenker's necrosis A form of severe hyaline degeneration or necrosis in skeletal muscle, occurring in severe infections.
Synonym: waxy degeneration, Zenker's necrosis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á